Corporate Board Profile
Tech Score: 33/100
2 mention(s) identify GARHENG KONG as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| LABCORP HOLDINGS INC. | 2018-03-30 | Dr. Kong holds an M.D., Ph.D. in Biomedical Engineering and an M.B.A. from Duke University. Dr. Kong brings to the Board knowledge and experience in both the healthcare and finance fields, as well as executive leadership, based on his medical background and his work in life science-related venture capital. | Holds an M.D., Ph.D. in Biomedical Engineering and has experience in healthcare and finance; his technical background and biomedical engineering degree indicate software-related skills. |
| LABCORP HOLDINGS INC. | 2019-03-29 | Dr. Kong holds an M.D., Ph.D. in Biomedical Engineering and an M.B.A. from Duke University. Dr. Kong brings to the Board knowledge and experience in both the healthcare and finance fields, as well as executive leadership, based on his medical background and his work in life science-related venture capital. | Holds an M.D., Ph.D. in Biomedical Engineering and has experience in healthcare and finance, including venture capital in life sciences, indicating technical and scientific expertise relevant to software and programming. |
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-30 | Dr. Kong holds an M.D., Ph.D. in Biomedical Engineering and an M.B.A. from Duke University. Dr. Kong brings to the Board knowledge and experience in both the healthcare and finance fields, as well as executive leadership, based on his medical background and his work in life science-related venture capital. |
| 2019-03-29 | Dr. Kong holds an M.D., Ph.D. in Biomedical Engineering and an M.B.A. from Duke University. Dr. Kong brings to the Board knowledge and experience in both the healthcare and finance fields, as well as executive leadership, based on his medical background and his work in life science-related venture capital. |
| 2020-04-01 | Dr. Kong has served as a director of the Company since December 1, 2013. Dr. Kong is the managing partner of HealthQuest Capital, a healthcare-focused investment firm, and was previously a general partner at Sofinnova Capital, a position he held from 2010 to 2013. Before joining Sofinnova, Dr. Kong was a general partner from 2000 to 2010 at Intersouth Partners, a venture capital firm where he was a founding investor or board member for various life science ventures, several of which were acquired by large pharmaceutical companies. Prior to his investing career, Dr. Kong was employed by GlaxoSmithKline, McKinsey & Company, and TherOx. |
| 2021-04-02 | Dr. Kong has served as a director of the Company since December 1, 2013. Dr. Kong has been managing partner of HealthQuest Capital, a healthcare-focused investment firm... Dr. Kong holds an M.D. and Ph.D. in Biomedical Engineering and an M.B.A. from Duke University. |
| 2022-03-31 | Garheng Kong has served as a director of the Company since December 1, 2013. Dr. Kong has been managing partner of HealthQuest Capital, a healthcare-focused investment firm... Knowledge and experience in both the healthcare and finance fields. |
| 2023-03-30 | Knowledge and experience in both the healthcare and finance fields; Executive leadership experience; Life science-related venture capital experience. |
Data sourced from SEC filings. Last updated: 2025-10-12